Adenocarcinoma, Bronchiolo-Alveolar
"Adenocarcinoma, Bronchiolo-Alveolar" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)
| Descriptor ID |
D002282
|
| MeSH Number(s) |
C04.557.470.200.025.030
|
| Concept/Terms |
Adenocarcinoma, Bronchiolo-Alveolar- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Bronchiolo Alveolar
- Adenocarcinomas, Bronchiolo-Alveolar
- Bronchiolo-Alveolar Adenocarcinoma
- Bronchiolo-Alveolar Adenocarcinomas
- Alveolar Cell Carcinoma
- Carcinoma, Alveolar
- Alveolar Carcinoma
- Alveolar Carcinomas
- Carcinomas, Alveolar
- Carcinoma, Bronchiolo-Alveolar
- Bronchiolo-Alveolar Carcinoma
- Bronchiolo-Alveolar Carcinomas
- Carcinoma, Bronchiolo Alveolar
- Carcinomas, Bronchiolo-Alveolar
- Carcinoma, Bronchioloalveolar
- Bronchioloalveolar Carcinoma
- Bronchioloalveolar Carcinomas
- Carcinomas, Bronchioloalveolar
- Adenocarcinoma, Alveolar
- Adenocarcinomas, Alveolar
- Alveolar Adenocarcinoma
- Alveolar Adenocarcinomas
- Carcinoma, Bronchiolar
- Bronchiolar Carcinoma
- Bronchiolar Carcinomas
- Carcinomas, Bronchiolar
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Bronchiolo-Alveolar".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Bronchiolo-Alveolar".
This graph shows the total number of publications written about "Adenocarcinoma, Bronchiolo-Alveolar" by people in this website by year, and whether "Adenocarcinoma, Bronchiolo-Alveolar" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 0 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 4 | 1 | 5 |
| 2006 | 4 | 2 | 6 |
| 2008 | 2 | 2 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma, Bronchiolo-Alveolar" by people in Profiles.
-
Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum. Adv Anat Pathol. 2013 Sep; 20(5):347-51.
-
Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2012 Oct; 7(10):1594-601.
-
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013 May; 137(5):685-705.
-
Invasive adenocarcinoma with bronchoalveolar features: a population-based evaluation of the extent of resection in bronchoalveolar cell carcinoma. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):591-600.e1.
-
The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: a population-based survival analysis. Ann Surg. 2011 Aug; 254(2):368-74.
-
Long-term safety and tolerability of sorafenib in patients with advanced non-small-cell lung cancer: a case-based review. Clin Lung Cancer. 2011 Jul; 12(4):212-7.
-
Bronchioloalveolar carcinoma: a translational perspective. Oncology (Williston Park). 2010 Sep; 24(10):907-8, 914.
-
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer. Clin Cancer Res. 2010 Mar 15; 16(6):1938-49.
-
Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer. J Thorac Oncol. 2009 Jan; 4(1):139-41.
-
Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.